Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
0.7700
Dollar change
+0.0030
Percentage change
0.39
%
Index- P/E- EPS (ttm)-0.97 Insider Own19.30% Shs Outstand31.32M Perf Week-2.41%
Market Cap26.35M Forward P/E- EPS next Y-0.98 Insider Trans1.23% Shs Float27.52M Perf Month-20.22%
Income-32.20M PEG- EPS next Q-0.33 Inst Own23.53% Short Float6.99% Perf Quarter-5.64%
Sales23.05M P/S1.14 EPS this Y41.97% Inst Trans20.74% Short Ratio20.44 Perf Half Y-41.22%
Book/sh1.87 P/B0.41 EPS next Y12.80% ROA-29.75% Short Interest1.92M Perf Year-57.22%
Cash/sh0.48 P/C1.61 EPS next 5Y- ROE-50.90% 52W Range0.67 - 2.60 Perf YTD-55.23%
Dividend Est.- P/FCF- EPS past 5Y34.16% ROI-40.39% 52W High-70.38% Beta1.41
Dividend TTM- Quick Ratio1.32 Sales past 5Y36.33% Gross Margin39.90% 52W Low14.82% ATR (14)0.07
Dividend Ex-Date- Current Ratio1.57 EPS Y/Y TTM52.64% Oper. Margin-257.90% RSI (14)43.52 Volatility5.78% 9.99%
Employees276 Debt/Eq0.52 Sales Y/Y TTM-2.09% Profit Margin-139.70% Recom1.00 Target Price3.50
Option/ShortYes / Yes LT Debt/Eq0.36 EPS Q/Q50.20% Payout- Rel Volume0.55 Prev Close0.77
Sales Surprise0.34% EPS Surprise-15.37% Sales Q/Q111.00% EarningsNov 07 BMO Avg Volume94.19K Price0.77
SMA20-3.17% SMA50-16.13% SMA200-35.87% Trades Volume51,887 Change0.39%
Date Action Analyst Rating Change Price Target Change
May-13-22Upgrade Alliance Global Partners Neutral → Buy $8.75
Apr-22-21Initiated Cowen Outperform $31
Mar-23-21Initiated Stifel Buy $30
Feb-25-21Initiated Cantor Fitzgerald Overweight $35
Feb-01-21Downgrade Alliance Global Partners Buy → Neutral $15.60 → $22.25
Aug-17-20Initiated Aegis Capital Buy $25
Aug-29-17Initiated Aegis Capital Buy $3.50
May-09-16Initiated Rodman & Renshaw Buy $12
Nov-21-24 08:30AM
Nov-08-24 06:02AM
Nov-07-24 07:40AM
06:30AM
Nov-04-24 08:30AM
08:30AM Loading…
Oct-30-24 08:30AM
Oct-23-24 08:30AM
Oct-17-24 08:30AM
Oct-15-24 08:30AM
Oct-09-24 05:35PM
Oct-08-24 09:09AM
Oct-02-24 12:00PM
Oct-01-24 08:30AM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
07:45AM Loading…
Aug-08-24 07:45AM
06:30AM
Jul-30-24 08:30AM
Jul-16-24 08:30AM
Jun-25-24 08:30AM
06:00AM
Jun-05-24 08:30AM
May-16-24 08:18AM
03:02AM
May-15-24 10:52AM
07:35AM
06:30AM
May-07-24 08:30AM
Apr-25-24 08:30AM
Apr-18-24 08:30AM
08:30AM Loading…
Apr-10-24 08:30AM
Apr-02-24 08:30AM
Apr-01-24 03:43PM
Mar-28-24 10:53AM
06:30AM
Mar-24-24 10:59AM
Mar-21-24 08:30AM
Mar-12-24 08:30AM
Feb-28-24 08:30AM
Feb-22-24 07:09AM
Feb-21-24 07:00AM
06:00AM
Jan-22-24 04:15PM
08:00AM
Jan-11-24 08:30AM
Dec-05-23 08:30AM
Nov-29-23 11:00AM
Nov-27-23 08:30AM
Nov-21-23 08:30AM
Nov-13-23 08:30AM
Nov-02-23 06:30AM
Nov-01-23 08:30AM
Oct-30-23 08:30AM
Oct-17-23 08:30AM
Oct-05-23 08:30AM
Oct-03-23 08:30AM
Sep-27-23 08:30AM
Aug-24-23 08:30AM
Aug-15-23 08:30AM
Aug-12-23 08:01AM
Aug-11-23 06:03AM
Aug-10-23 06:30AM
Aug-08-23 08:30AM
Aug-04-23 08:16AM
Aug-03-23 08:45AM
Aug-02-23 08:30AM
Jul-26-23 08:30AM
Jul-24-23 08:30AM
Jul-06-23 08:30AM
Jun-26-23 08:30AM
Jun-07-23 08:30AM
Jun-01-23 08:30AM
May-18-23 08:30AM
May-16-23 11:59AM
May-11-23 06:30AM
May-09-23 08:30AM
May-05-23 12:14PM
May-04-23 08:30AM
02:00AM
May-02-23 08:30AM
Apr-04-23 08:00AM
Mar-27-23 08:00AM
Mar-22-23 08:35AM
Mar-14-23 08:00AM
Mar-12-23 08:17AM
Mar-09-23 06:30AM
Mar-02-23 08:00AM
Feb-28-23 05:00AM
Feb-27-23 08:00AM
Feb-24-23 08:00AM
Feb-23-23 08:00AM
Feb-08-23 08:00AM
Feb-06-23 09:00AM
Jan-24-23 08:00AM
Jan-09-23 08:00AM
Jan-04-23 10:38AM
Jan-03-23 08:00AM
Dec-28-22 12:05AM
Dec-22-22 08:00AM
Dec-19-22 08:00AM
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nelson Steven CharlesChief Commercial OfficerNov 12 '24Buy0.915,0004,54655,000Nov 14 04:15 PM
Nelson Steven CharlesChief Commercial OfficerSep 10 '24Buy0.845,0004,22145,000Sep 12 04:37 PM
Nelson Steven CharlesChief Commercial OfficerSep 11 '24Buy0.805,0004,02250,000Sep 12 04:37 PM
Nelson Steven CharlesChief Commercial OfficerSep 06 '24Buy0.845,0004,20035,000Sep 10 06:00 AM
Nelson Steven CharlesChief Commercial OfficerSep 05 '24Buy0.825,0004,09130,000Sep 10 06:00 AM
Nelson Steven CharlesChief Commercial OfficerSep 09 '24Buy0.805,0004,00040,000Sep 10 06:00 AM
Raphael ErezChief Executive OfficerAug 27 '24Buy0.885,0004,4001,937,059Aug 28 06:12 PM
Nelson Steven CharlesChief Commercial OfficerAug 23 '24Buy0.955,0004,75025,000Aug 23 04:05 PM
Nelson Steven CharlesChief Commercial OfficerAug 22 '24Buy0.945,0004,72520,000Aug 23 04:05 PM
Nelson Steven CharlesChief Commercial OfficerAug 21 '24Buy0.935,0004,67215,000Aug 23 04:05 PM
Raphael ErezChief Executive OfficerAug 21 '24Buy0.955,0004,7501,932,059Aug 23 04:05 PM
Raphael ErezChief Executive OfficerAug 20 '24Buy0.935,0004,6501,927,059Aug 23 04:05 PM
Nelson Steven CharlesChief Commercial OfficerAug 20 '24Buy0.945,0004,68410,000Aug 20 04:01 PM
Nelson Steven CharlesChief Commercial OfficerAug 19 '24Buy0.925,0004,5985,000Aug 20 04:01 PM
Raphael ErezChief Executive OfficerAug 19 '24Buy0.905,0004,5001,922,059Aug 20 04:01 PM
Raphael ErezChief Executive OfficerAug 16 '24Buy0.905,0004,4801,917,059Aug 20 04:01 PM